We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 19, 2021

Effects of Ertugliflozin on Kidney Composite Outcomes, Renal Function, and Albuminuria in Patients With T2D



Additional Info

Effects of Ertugliflozin on Kidney Composite Outcomes, Renal Function and Albuminuria in Patients With Type 2 Diabetes Mellitus: An Analysis From the Randomised VERTIS CV Trial
Diabetologia 2021 Jun 01;64(6)1256-1267, DZI Cherney, B Charbonnel, F Cosentino, S Dagogo-Jack, DK McGuire, R Pratley, WJ Shih, R Frederich, M Maldonado, A Pong, CP Cannon, VERTIS CV Investigators

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading